Skip to main content
. 2020 Dec 10;147(4):1031–1040. doi: 10.1007/s00432-020-03486-2

Table 3.

Correlation between GATA6 and PIK3CA within the patient cohort

Factor Total GATA6 p value
Negative Positive
Entire cohort
 PIK3CA Normal 415 94.5% 379 91.3% 36 8.7%
Amplified 24 5.5% 15 62.5% 9 37.5%  < 0.001
Patients without neoadjuvant treatment
 PIK3CA Normal 186 94.4% 173 93.0% 13 7.0%
Amplified 11 5.6% 9 81.8% 2 18.2% 0.174
Patients with neaodjuvant treatment
 PIK3CA Normal 229 94.6% 206 90.0% 23 10.0%
Amplified 13 5.4% 6 46.2% 7 53.8%  < 0.001